Welcome to "This Week in Biotech," where we highlight top biotech stories in a fast-hitting style that lets you get back to your weekend. Let's get started.
Human Genome Sciences
We had a potentially messy story on our hands with Cubist Pharmaceuticals
Finally, Array BioPharma
See you next week!
Fool contributor David Williamson holds no position in any company mentioned. Check out his holdings and a short bio. Motley Fool newsletter services have recommended buying shares of GlaxoSmithKline and Vertex Pharmaceuticals. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.